NDGA did not interfere with major growth promoting signaling pathways such as the activation of receptor tyrosine kinases, PI3-kinase/p70s6k or the ERK cascade demonstrating that NDGA is not acting as a general kinase inhibitor in pancreatic and cervical cancer cell lines. The gene discussed is RPS6KB1; the disease is cervical carcinoma.